FAP and neoplasm: The destruction of tumor stroma with alpha-emitters in combination with other non-radioactive agents (e.g., chemotherapeutics, targeted drug delivery systems, CAR T-cell therapy etc.)might also be a promising therapy approach, and [225Ac]Ac-DOTAGA.Glu.(FAPi)2 might be an interesting candidate for FAP-TAT in the future.